7-135135098-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178563.4(AGBL3):āc.2600G>Cā(p.Gly867Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,551,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL3 | NM_178563.4 | c.2600G>C | p.Gly867Ala | missense_variant | 17/17 | ENST00000436302.6 | NP_848658.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL3 | ENST00000436302.6 | c.2600G>C | p.Gly867Ala | missense_variant | 17/17 | 2 | NM_178563.4 | ENSP00000388275 | P2 | |
CYREN | ENST00000459937.5 | n.356+33651C>G | intron_variant, non_coding_transcript_variant | 1 | ||||||
AGBL3 | ENST00000435976.6 | c.2111-12715G>C | intron_variant | 5 | ENSP00000401220 | A2 | ||||
CYREN | ENST00000464070.1 | n.187+12879C>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000260 AC: 4AN: 153558Hom.: 0 AF XY: 0.0000123 AC XY: 1AN XY: 81474
GnomAD4 exome AF: 0.0000343 AC: 48AN: 1399026Hom.: 0 Cov.: 31 AF XY: 0.0000319 AC XY: 22AN XY: 690018
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.2600G>C (p.G867A) alteration is located in exon 17 (coding exon 16) of the AGBL3 gene. This alteration results from a G to C substitution at nucleotide position 2600, causing the glycine (G) at amino acid position 867 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at